[go: up one dir, main page]

GB0409080D0 - Compounds which interact with protein kinases - Google Patents

Compounds which interact with protein kinases

Info

Publication number
GB0409080D0
GB0409080D0 GBGB0409080.9A GB0409080A GB0409080D0 GB 0409080 D0 GB0409080 D0 GB 0409080D0 GB 0409080 A GB0409080 A GB 0409080A GB 0409080 D0 GB0409080 D0 GB 0409080D0
Authority
GB
United Kingdom
Prior art keywords
interact
compounds
protein kinases
kinases
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0409080.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofocus Discovery Ltd
Original Assignee
Biofocus Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofocus Discovery Ltd filed Critical Biofocus Discovery Ltd
Priority to GBGB0409080.9A priority Critical patent/GB0409080D0/en
Publication of GB0409080D0 publication Critical patent/GB0409080D0/en
Priority to PCT/GB2005/001566 priority patent/WO2005103036A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0409080.9A 2004-04-23 2004-04-23 Compounds which interact with protein kinases Ceased GB0409080D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0409080.9A GB0409080D0 (en) 2004-04-23 2004-04-23 Compounds which interact with protein kinases
PCT/GB2005/001566 WO2005103036A1 (en) 2004-04-23 2005-04-22 Pyrimidin-4-yl-1h-indazol-5yl-amines as chk1 kinases inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0409080.9A GB0409080D0 (en) 2004-04-23 2004-04-23 Compounds which interact with protein kinases

Publications (1)

Publication Number Publication Date
GB0409080D0 true GB0409080D0 (en) 2004-05-26

Family

ID=32344283

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0409080.9A Ceased GB0409080D0 (en) 2004-04-23 2004-04-23 Compounds which interact with protein kinases

Country Status (2)

Country Link
GB (1) GB0409080D0 (en)
WO (1) WO2005103036A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2644910C (en) * 2006-03-31 2014-01-28 Abbott Laboratories Indazole compounds
US20100144756A1 (en) * 2007-07-13 2010-06-10 Bolea Christelle Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
CN101883764B (en) * 2007-12-07 2013-11-13 诺华股份有限公司 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
WO2009089352A1 (en) 2008-01-08 2009-07-16 Array Biopharma Inc. Pyrrolopyridines as kinase inhibitors
CA2711741A1 (en) 2008-01-09 2009-07-16 Array Biopharma Inc. Pyrazolopyridines as kinase inhibitors
CL2009001152A1 (en) 2008-05-13 2009-10-16 Array Biopharma Inc Compounds derived from n- (4- (nitrogen cycloalkyl-1-yl) -1h-pyrrolo [2,3-b] pyridin-3-yl) amide, kinase inhibitors; Preparation process; pharmaceutical composition; and its use for the treatment of a proliferative disease.
US8481557B2 (en) 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
RU2627841C2 (en) 2010-11-16 2017-08-14 Эррэй Биофарма Инк. Combination of chekpoint-kinase 1 inhibitors and wee 1 kinase inhibitors
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU54202A (en) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Indazole compounds,pharmaceutical compositions,and methods for mediating or inhibiting cell proliferation
EP1380576B1 (en) * 2001-04-16 2009-11-25 Eisai R&D Management Co., Ltd. 1h-indazole compounds inhibiting jnk
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
EP1678147B1 (en) * 2003-09-15 2012-08-08 Lead Discovery Center GmbH Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases

Also Published As

Publication number Publication date
WO2005103036A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
GB0409080D0 (en) Compounds which interact with protein kinases
GB0514482D0 (en) Protein
GB0417887D0 (en) Protein
GB0404889D0 (en) Compounds which interact with protein kinases
GB0426259D0 (en) Compounds which interact with protein kinases
GB0401882D0 (en) Protein
GB0504075D0 (en) Plac-1-like protein
GB0508160D0 (en) Protein
GB0512426D0 (en) Protein
GB0513561D0 (en) Protein
GB0513690D0 (en) Protein
GB0514717D0 (en) Protein
GB0514718D0 (en) Protein
GB0514789D0 (en) Protein
GB0515180D0 (en) Protein
GB0515436D0 (en) Protein
GB0515438D0 (en) Protein
GB0515443D0 (en) Protein
GB0516302D0 (en) Protein
GB0513653D0 (en) Protein stability
GB0422058D0 (en) Protein
GB0402811D0 (en) Protein
GB0422440D0 (en) Protein
GB0400087D0 (en) Protein
GB0400783D0 (en) Protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)